Description

8H-Imidazo[4,5-G]Quinazolin-8-One, 3,5-Dihydro-4,9-Dihydroxy-2,3,6-Trimethyl- (9Ci) is a complex heterocyclic organic compound with the CAS number 121732-25-0, serving as a key advanced intermediate in modern synthetic chemistry. Its intricate fused-ring structure makes it a valuable building block for the development of novel active pharmaceutical ingredients (APIs) and specialty fine chemicals. This high-purity compound is primarily targeted at research institutions and industrial manufacturers in the pharmaceutical, agrochemical, and advanced material sectors.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly for targeted therapies.
• Agrochemical Research: Used in the development of new herbicides, fungicides, and plant growth regulators.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct sophisticated molecular architectures.
• Biochemical Research: Serves as a scaffold or inhibitor in biochemical pathway studies and enzyme research.
• Material Science: Potential precursor for the synthesis of organic electronic materials or specialty dyes.
• Contract Research & Manufacturing (CRAM): Supplied to CROs and CDMOs for custom synthesis projects.

Basic Information

Product Name	8H-Imidazo[4,5-G]Quinazolin-8-One, 3,5-Dihydro-4,9-Dihydroxy-2,3,6-Trimethyl- (9Ci)
CAS No.	121732-25-0
Molecular Formula	C12H12N4O3
Molecular Weight	260.25 g/mol
Synonyms	3,5-Dihydro-4,9-dihydroxy-2,3,6-trimethyl-8H-imidazo[4,5-g]quinazolin-8-one; 2,3,6-Trimethyl-4,9-dihydroxy-3,5-dihydro-8H-imidazo[4,5-g]quinazolin-8-one; 8H-Imidazo[4,5-g]quinazolin-8-one, 3,5-dihydro-4,9-dihydroxy-2,3,6-trimethyl-; Imidazoquinazolinone derivative; CAS 121732-25-0
EINECS	Contact for details

Quality Control

Our production of 8H-Imidazo[4,5-G]Quinazolin-8-One adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot is characterized and tested using advanced analytical techniques including HPLC, NMR, and mass spectrometry. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment. We support compliance with cGMP and ICH Q7 guidelines for advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This compound is light-sensitive (store away from light). Keep away from incompatible materials. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.